Novartis

photo of a pair of binoculars perched on a rock aimed at the rising sun
Biotech

Are Lilly, Novartis eyeing the PD-1xVEGF field? Execs weigh in

Both Eli Lilly and Novartis once had their PD-1 inhibitor dreams shattered, and both know the VEGF realm.
Angus Liu Jun 4, 2025 1:00pm
illegal trading stock market

5 people accused of insider trading tied to Novartis buy

May 27, 2025 2:37pm
An open book with pages turning on a wooden table set

Erasca looks to partner off late-stage melanoma asset

May 13, 2025 10:38am
question unanswered wonder ask

PTC and Novartis’ Huntington's data fail to convince investors

May 6, 2025 7:25am
Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand

Novartis pays $800M to buy Regulus for phase 3-ready kidney drug

Apr 30, 2025 9:30am
Broom sweep clean

Novartis axes osteoarthritis asset and radioligand therapy

Apr 29, 2025 5:24am